Search Results
Paclitaxel With Pertuzumab Plus Trastuzumab in Metastatic Breast Cancer
APT: adjuvant paclitaxel and trastuzumab for node-negative, HER2+ breast cancer
Dr. Pegram on Pertuzumab Plus Trastuzumab and Chemotherapy in Breast Cancer
ADAPT: de-escalated neoadjuvant pertuzumab+trastuzumab with or without paclitaxel in HR-/HER2+ eBC
Frontline Pertuzumab for Metastatic Breast Cancer
Sara Tolaney, SABCS 2022: Adjuvant paclitaxel and trastuzumab for node-negative HER2+ breast cancer
CLEOPATRA Trial: Pertuzumab Regimen for Frontline HER2-Positive Metastatic Breast Cancer
Study of Atezolizumab with Pertuzumab and Trastuzumab in HER2- Positive Metastatic Breast Cancer
First-Line Treatment of HER2-Positive Metastatic Breast Cancer
Dr. Jahanzeb on the Benefit of Pertuzumab Plus Trastuzumab in HER2+ Breast Cancer
5-year correlative analysis of ATEMPT: adjuvant T-DM1 vs paclitaxel+trastuzumab for stage I HER2+ BC
HER-RAM: investigating trastuzumab, ramucirumab and paclitaxel for the second-line treatment of GC
